Amylyx Pharmaceuticals Inc (AMLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,999 | 170,552 | 170,201 | 135,258 | 247,760 |
| Marketable Securities | 234,813 | 202,741 | 201,161 | 219,787 | 109,516 |
| Receivables | 4,091 | 20,351 | 40,050 | 29,353 | 33,473 |
| Inventories | N/A | N/A | 38,323 | 32,374 | 24,858 |
| TOTAL | $326,722 | $410,534 | $464,666 | $434,110 | $427,394 |
| Non-Current Assets | |||||
| PPE Net | 1,473 | 2,459 | 2,686 | 2,761 | 2,637 |
| Other Non-Current Assets | 3,967 | 4,464 | 50,102 | 29,713 | 23,557 |
| TOTAL | $5,440 | $6,923 | $52,788 | $32,474 | $26,194 |
| Total Assets | $332,162 | $417,457 | $517,454 | $466,584 | $453,588 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,955 | 21,453 | 22,061 | 6,371 | 24,695 |
| Accrued Expenses | 62,757 | 67,874 | 57,724 | 37,045 | 37,241 |
| TOTAL | $70,081 | $91,639 | $82,042 | $45,617 | $64,082 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 772 | 1,382 | 1,980 | 2,567 | 3,141 |
| TOTAL | $772 | $1,382 | $1,980 | $2,567 | $3,141 |
| Total Liabilities | $70,853 | $93,021 | $84,022 | $48,184 | $67,223 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,082 | 68,006 | 67,782 | 67,518 | 67,378 |
| Common Shares | 7 | 7 | 7 | 7 | 7 |
| Retained earnings | -496,442 | -423,742 | -304,949 | -309,680 | -330,573 |
| Other shareholders' equity | -97 | -77 | 197 | -151 | -72 |
| TOTAL | $261,309 | $324,436 | $433,432 | $418,400 | $386,365 |
| Total Liabilities And Equity | $332,162 | $417,457 | $517,454 | $466,584 | $453,588 |